These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12021392)

  • 1. Synergistic induction of apoptosis in human myeloid leukemia cells by phorbol 12-myristate 13-acetate and flavopiridol proceeds via activation of both the intrinsic and tumor necrosis factor-mediated extrinsic cell death pathways.
    Cartee L; Smith R; Dai Y; Rahmani M; Rosato R; Almenara J; Dent P; Grant S
    Mol Pharmacol; 2002 Jun; 61(6):1313-21. PubMed ID: 12021392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C-dependent activation of the tumor necrosis factor receptor-mediated extrinsic cell death pathway underlies enhanced apoptosis in human myeloid leukemia cells exposed to bryostatin 1 and flavopiridol.
    Cartee L; Maggio SC; Smith R; Sankala HM; Dent P; Grant S
    Mol Cancer Ther; 2003 Jan; 2(1):83-93. PubMed ID: 12533676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
    Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S
    Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-alpha-mediated process.
    Rahmani M; Dai Y; Grant S
    Exp Cell Res; 2002 Jul; 277(1):31-47. PubMed ID: 12061815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).
    Almenara J; Rosato R; Grant S
    Leukemia; 2002 Jul; 16(7):1331-43. PubMed ID: 12094258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cells.
    Wang S; Wang Z; Dent P; Grant S
    Blood; 2003 May; 101(9):3648-57. PubMed ID: 12522001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
    Dai Y; Rahmani M; Grant S
    Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosis.
    Decker RH; Wang S; Dai Y; Dent P; Grant S
    Cancer Biol Ther; 2002; 1(2):136-44. PubMed ID: 12170773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells.
    Rosato RR; Almenara JA; Cartee L; Betts V; Chellappan SP; Grant S
    Mol Cancer Ther; 2002 Feb; 1(4):253-66. PubMed ID: 12467221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells.
    Rosato RR; Almenara JA; Dai Y; Grant S
    Mol Cancer Ther; 2003 Dec; 2(12):1273-84. PubMed ID: 14707268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactive caspase 3 activates Akt in human leukemia cells susceptible or resistant to apoptosis induced by phorbol ester.
    Hah JO; Lee KA; Choi YJ; Kim WD; Park JW; Kwon TK
    Int J Oncol; 2003 May; 22(5):1111-6. PubMed ID: 12684678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway.
    Decker RH; Dai Y; Grant S
    Cell Death Differ; 2001 Jul; 8(7):715-24. PubMed ID: 11464216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.
    Yu C; Krystal G; Dent P; Grant S
    Clin Cancer Res; 2002 Sep; 8(9):2976-84. PubMed ID: 12231544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
    Wang S; Wang Z; Grant S
    Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UCN-01 (7-hydroxystauorsporine) blocks PMA-induced maturation and reciprocally promotes apoptosis in human myelomonocytic leukemia cells (U937).
    Rahmani M; Grant S
    Cell Cycle; 2002; 1(4):273-81. PubMed ID: 12429947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol.
    Gao N; Dai Y; Rahmani M; Dent P; Grant S
    Mol Pharmacol; 2004 Oct; 66(4):956-63. PubMed ID: 15235103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol.
    Rosato RR; Almenara JA; Yu C; Grant S
    Mol Pharmacol; 2004 Mar; 65(3):571-81. PubMed ID: 14978235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells.
    Sordet O; Bettaieb A; Bruey JM; Eymin B; Droin N; Ivarsson M; Garrido C; Solary E
    Cell Death Differ; 1999 Apr; 6(4):351-61. PubMed ID: 10381626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.